Cargando…
Discovery of Dihydrochalcone as Potential Lead for Alzheimer’s Disease: In Silico and In Vitro Study
By the virtual screening method we have screened out Dihydrochalcone as a top-lead for the Alzheimer’s disease using the database of about 32364 natural compounds. The binding affinity of this ligand to amyloid beta (A[Image: see text]) fibril has been thoroughly studied by computer simulation and e...
Autores principales: | Viet, Man Hoang, Chen, Chun-Yu, Hu, Chin-Kun, Chen, Yun-Ru, Li, Mai Suan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3832475/ https://www.ncbi.nlm.nih.gov/pubmed/24260164 http://dx.doi.org/10.1371/journal.pone.0079151 |
Ejemplares similares
-
Discovery of DNA dyes Hoechst 34580 and 33342 as good candidates for inhibiting amyloid beta formation: in silico and in vitro study
por: Thai, Nguyen Quoc, et al.
Publicado: (2016) -
Dihydrochalcone glycosides from Oxytropis myriophylla
por: She, Gaimei, et al.
Publicado: (2011) -
Antioxidant Structure–Activity Relationship Analysis of Five Dihydrochalcones
por: Li, Xican, et al.
Publicado: (2018) -
Neohesperidin Dihydrochalcone and Neohesperidin Dihydrochalcone-O-Glycoside Attenuate Subcutaneous Fat and Lipid Accumulation by Regulating PI3K/AKT/mTOR Pathway In Vivo and In Vitro
por: Kwon, Minseo, et al.
Publicado: (2022) -
Dihydrochalcones and Diterpenoids from Pteris ensiformis and Their Bioactivities
por: Shi, Yu-Sheng, et al.
Publicado: (2017)